NOVARTIS AG (NVSEF)
Clinical trial NCT05798117 updates: 1. completion date: 2026-09-09 → 2026-09-24 2. primary completion date: 2026-09-09 → 2026-09-24
Clinical trial NCT05798117 updates: 1. completion date: 2026-09-09 → 2026-09-24 2. primary completion date: 2026-09-09 → 2026-09-24
📉 **NEGATIVE** • Medium confidence analysis (62%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (24%) **Content type:** Clinical